Tamarly Intelligence
Private raises · SEC Form D

AI3 Bio, Inc.: $48 million Raised, SEC Form D Filings

AI3 Bio, Inc., a private biotechnology company in Watertown, Massachusetts, reported $48 million sold in a Form D filed 4 November 2026.

Company · Biotechnology · MA · SEC CIK 2019875 · Company page

Share this pageLinkedInXEmail

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
4 Nov 2026New notice$48 million$48 millionBiotechnologyForm D
4 Nov 2026New noticeNot fixed$0BiotechnologyForm D
20 Oct 2025New notice$17 million$17 millionPharmaceuticalsForm D

Questions and answers

How much has AI3 Bio, Inc. raised?
AI3 Bio, Inc. reported $48 million sold in its largest Form D notice on file; its latest notice was filed on 4 November 2026. Form D amounts are what the issuer reported to the SEC.
What is AI3 Bio, Inc.?
AI3 Bio, Inc. is a company in biotechnology, based in Watertown, Massachusetts, according to its SEC Form D filings.
How many Form D notices has AI3 Bio, Inc. filed?
3 notices between 20 October 2025 and 4 November 2026 in Tamarly's record, which starts on 1 October 2025.
Get an email when AI3 Bio, Inc. files again
No account needed. Choose one:
See every Form D raise as it arrives, free and with no account.Explore for free

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "AI3 Bio, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/2019875, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.